Agios Pharmaceuticals Announced It Will Present New Data And Results From Its Phase 3 Study On AG-946 At The 66th American Society Of Hematology Annual Meeting In San Diego, California From December 7-10, 2024
agios pharmaceuticals宣佈將於2024年12月7日至10日在美國血液學會第66屆年會上,發佈其AG-946第3階段研究的新數據和結果